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Response 
To the Editor: 
We appreciate the comments of Growdon (1986) 
regarding our disappointing results with phosphati- 
dyIchoIine (PC) in the treatment of tardive dyskinesia 
(TD). This neuroleptic-induced syndrome is of such 
importance that any potential treatment needs a thor- 
ough analysis before it is discarded as either practi- 
cally or theoretically not useful. Growdon is correct 
that we presented mean data (Domino et al. 1985), 
and therefore, individual patient differences were not 
emphasized. As others have observed, we also had 
individua1 TD patients who improved. However, one 
of our most dramatic improvements occurred in a 
Lafayette Clinic patient who received only placebo 
and no PC. Hence, we decided to emphasize the 
group mean data on PC, which, in general, did not 
differ from the mean data on placebo using a double- 
blind experimental design. 
Growdon feels that our findings differ from those 
of most published reports and that PC is the drug of 
choice for TD; he cites a review by Schiefe and Grow- 
don (1982) on the treatment of TD. That review in- 
cludes open studies in estimates of efficacy of PC, 
but does not include three recent double-blind studies 
(Perez-Cruet et al. 198 1; Anderson et al. 1982; Jeste 
and Wyatt 1982a). In our paper. we listed all the 
double-blind studies that have been published so far 
on PC for TD. Excluding our own study. these in- 
volve a total of 28 PC-treated patients, 18 of whom 
failed to improve. Therefore. we cannot agree with 
Growdon that our findings m~kedly differ from other 
published reports. Other investigators who have re- 
viewed the literature on the treatment of TD do not 
con&de that PC is the treatment of choice (Jeste and 
Wyatt 1982b; Casey 1985). In our opinion, at the 
present time, there is no satisfactory treatment of TD. 
Among the double-blind studies with PC, im- 
provement of TD occurred only in the two studies in 
which neuroleptic maintenance treatment had been 
withdrawn (Jackson et al. 1979: Perez-Cruet et al. 
1981). This suggests that improvement may have been 
due to spontaneous recovery from withdrawal dys- 
klnesia rather than to PC. Future studies must take 
into account TD patients who spontaneously recover 
following neuroleptic withdrawal over a prolonged 
period of time (years), as opposed to those TD pa- 
tients who are maintained on neuroleptic medication. 
It should be emphasized that our TD patients contin- 
ued to be on psychotropic drugs, because their psy- 
chiatric condition would not ethically allow drug 
withdrawal. 
Growdon correctly points out that the rate of neu- 
ronal firing appears to determine the extent to which 
cholinergic neurons are sensitive to precursor avail- 
ability. If TD patients have supersensitive dopamine 
receptors on their striatal cholinergic neurons, such 
neurons would have a lower firing rate, making them 
unlikely to take advantage of any increases in avail- 
able choline. Theoretically. PC is less implant as 
a precursor of acetylcholine in a cholinergic neuron 
whose firing rate is further diminished by an over- 
704 BIOL PSYCHIATK\I 
108621~707 70: 
active dopaminergic system. As neurotransmitter 
turnover best reflects overall cholinergic function. it 
is important to note that elevated choline levels have 
not been shown in animal studies to alter acetylcho- 
line turnover in normally functioning cholinergic neu- 
rons (Eckemas et al. 1977: Brunello CI al 19821. 
Hence, we remain convinced that, unfortunately. PC 
is an ineffective treatment of TD both on a theoretical 
as well as a practical basis. For the benefit of all TD 
patients, nothing would please us more than to have 
future studies prove us wrong. 
University of Michigan 
Ann Arbor, MI 48109-0010 
Lafayette Clinic 
Detroit, MI 48207 
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Zinc and Childhood Hyperactivity 
To the Editor: 
It is well known that complications of pregnancy 
increase the risk of defective offspring, but specific 
correlations are more difficult to prove. There are 
some indications that zinc deficiency in pregnancy 
and pre-eclampsia may contribute to production of 
the hyperactive syndrome in progeny. Low zinc oc- 
curs consistently in severe pre-eclampsia (Hahn and 
Fuchs 1974; Brophy et al. 1985). Zinc deficiency is 
known to lead to a hyperactive syndrome in rats (Halas 
and Sandstead 1975). Childhood hyperactivity has 
been retrospectively associated with pre-eclampsia by 
Pasamanick and coworkers (Rogers et al. 1955). Ta- 
blc I gives results of our statistical power analysis 
(Thomas and Cart 1977) of the association of hy 
pertension in pregnancy to syndromes associated with 
pcrinatal complications according to these authors 
(Rogers ct al. 1955; Pasamanick and Knobloch 1961 i 
Our statistical analysis of their data relating the in-- 
cidence of hypertension in pregnancy in cases with 
a designated childhood disorder as compared to con- 
trols suggests that reading disorders and hyperactivity 
may be relatively more frequent than other negative 
outcomes. Their data do not support an association 
of mental retardation with pre-eclampsia. 
The above would suggest that there may be anal- 
ogous zinc deficiencies during development both in 
the hyperactive but previously zinc-deficient rat and 
